Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded access program.

Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

Zeteo Biomedical LLC today announced the launch of its ZTech-P CygnusMR™ and CygnusSDX™ delivery devices, designed for ...

A Massachusetts man is the only one in the country who has tried a nasal spray treatment for Alzheimer's. He's going to help ...